Category: Feature Stories

The European Medicines Agency (EMA) wants to decide already in few weeks on a permission recommendation for two CoV vaccines, as the agency communicated on Tuesday. After the US pharmaceutical group Moderna, the German company Biontech and the US pharmaceutical giant Pfizer have now also applied for approval of their vaccine in the EU. The EMA must now examine the applications, by 29 December at the latest a result for the Biontech Pfizer vaccine should be available, by 12 January for that of Moderna. The final decision will be made…

Read More

After the US pharmaceutical company Moderna, the German company Biontech and the US pharmaceutical giant Pfizer have now applied to the European Medicines Agency (EMA) for approval of their coronavirus vaccine in the EU. The conditional marketing authorization application was submitted yesterday, Biontech and Pfizer announced today. The EMA must now review the applications. It is not clear how long this will take. If the EMA recommends a conditional approval, the vaccine could still be used in December, Biontech announced. The final decision will be made by the EU Commission,…

Read More

Disasters, conflicts, climate change and now the corona virus have plunged millions of people into misery. Famines even threatened, warned UN emergency aid coordinator Mark Lowcock. The UN expects that next year more people will need help and support than ever before: a total of 235 million people, an increase of 40 percent within one year. A year ago the figure was 168 million, the year before 146 million people. Next year, the UN wants to help 160 million people in 56 countries. The others are taken care of by…

Read More

A new Covid-19 simulator makes the aerosol dispersion in offices, classrooms and gondolas visible and calculates where the risk of infection is high.Already towards the end of the first lockdown, Gerald Dipplinger and his team asked themselves the question: “If we are allowed back into the office – an open-plan office in the Vienna DC Tower – how is it determined how many people are allowed in? 30, 50 or 70 percent of the workforce? The answer – 30 percent – came more from the gut and was not very…

Read More

The corona pandemic also affects Christmas. A survey was conducted to find out how Austrians celebrate Christmas this year. Two thirds want to celebrate Christmas as usualThe Christmas celebration is very meaningful for Austrians, but Corona changes this time noticeably: “73 per cent of the respondents are convinced that the time before Christmas becomes fundamentally different this year. This is particularly evident at the Christmas markets: “If 75 percent still wanted to visit a market in 2019, this figure will shrink to 25 percent in 2020. More than half even…

Read More

The SARS-CoV-2 vaccines, which are about to be approved, have been tested on tens of thousands of people and have comparable efficacy to other vaccines, experts told journalists on Thursday. The SARS-CoV-2 vaccines would also be suitable for older people with concomitant diseases (comorbidities). Pregnant women, cancer patients, people with weakened immune systems and children were not included in the clinical trials and therefore should not be vaccinated, they said. “Vaccinations are a preventive measure and are administered to healthy individuals. Therefore, the requirements for clinical trials are particularly high…

Read More

Chancellor Sebastian Kurz stressed on Thursday that vaccination against the corona virus would be the “game changer in the fight against the pandemic”. “I am glad that we now have certainty that we will start vaccinating in Austria as early as January and can thus return to normality as early as next summer,” he said during a visit to the biotech company Polymun in Klosterneuburg. The next months would be still very challenging, but there is by the vaccine light at the end of the tunnel , repeated the Chancellor…

Read More

U.S. manufacturer Moderna plans to start supplying its CoV vaccine to the European Union as early as December – provided the product receives regulatory approval. The company announced this yesterday. It confirmed the conclusion of a framework agreement with the EU Commission. According to the agreement, initially 80 million vaccine doses are to be delivered, with an option for 80 million additional units. “Moderna expects to begin shipping mRNA-1273 to the European Union in December 2020,” the company confirmed. Strategic partners in Europe are Lonza in Switzerland and Rovi in…

Read More

The announcement of a corona vaccine provides relief worldwide. But now Biontech has commented on the side effects. Vaccines against the corona virus are being worked on under high pressure worldwide – some manufacturers are now even ready to say that the first vaccinations are realistically expected before the end of this year. These include the vaccine developed by the German company Biontech in collaboration with the U.S. pharmaceutical giant Pfizer. The researchers were amazed not only by its rapid development, but also by its apparently very high efficacy. Around…

Read More